Article

Firm to help develop novel ophthalmic devices

Menlo Park, CA—Retina expert and inventor Eugene de Juan, MD, will launch a new business devoted to helping develop novel ophthalmic medical devices.

Menlo Park, CA-Retina expert and inventor Eugene de Juan, MD, will launch a new business devoted to helping develop novel ophthalmic medical devices.

The firm, called ForSight, will be based on an incubator model used by The Foundry, an acclaimed medical device incubator that has jumpstarted nine companies since 1998.

Dr. de Juan, who is professor of ophthalmology, University of Southern California and chief executive officer of the Doheny Retina Institute, will serve as founder and chief executive officer of ForSight. An inventor himself, he has helped to found five separate companies.

ForSight is evaluating ideas from ophthalmic entrepreneurs and will pick one project in which it will provide engineering support and financing until a working model can be established. The incubator will share technical support with The Foundry until it can run independently.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.